University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Envarsus XR® in Adolescent Renal Transplant Recipients

Phase 4

Active, not recruiting

Conditions: Kidney Transplantation
Renal Transplantation
Grafting, Kidney

Interventions: Drug: Envarsus XR
Drug: Tacrolimus

First Posted Date: 2017-08-30

Last Posted Date: 2023-02-09

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 28

Registration Number: NCT03266393

Locations: 🇺🇸
UCLA Transplantation Services, Los Angeles, California, United States

Pre-Operative Testing for Cataract Surgery Among Adults in LA County

Not Applicable

Completed

Conditions: Cataract

Interventions: Behavioral: No Pre-Op Testing for Cataract Surgeries

First Posted Date: 2017-08-18

Last Posted Date: 2017-08-18

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 1798

Registration Number: NCT03253874

Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response

Not Applicable

Completed

Conditions: Children With Autism

Interventions: Behavioral: PARENT focused intervention
Behavioral: CHILD focused intervention

First Posted Date: 2017-08-17

Last Posted Date: 2024-12-05

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 81

Registration Number: NCT03253081

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

Phase 1

Completed

Conditions: HIV/AIDS
Antiviral Drug Adverse Reaction
Antiviral Toxicity
Mitochondrial Alteration

Interventions: Drug: Switch to E/C/FTC/TAF daily

First Posted Date: 2017-08-16

Last Posted Date: 2022-05-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 26

Registration Number: NCT03251144

Locations: 🇺🇸
UCLA CARE Center, Los Angeles, California, United States

Target Engagement and Response to Oxytocin

Phase 4

Completed

Conditions: Schizophrenia

Interventions: Drug: Oxytocin nasal spray
Behavioral: Health Management
Drug: Placebo nasal spray
Behavioral: Social Cognition Skills Training

First Posted Date: 2017-08-10

Last Posted Date: 2025-03-21

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 120

Registration Number: NCT03245437

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

FODMAP Reintroduction in Irritable Bowel Syndrome

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome With Mixed Bowel Habits
Irritable Bowel Syndrome With Diarrhea

Interventions: Other: Dietary Intervention

First Posted Date: 2017-08-10

Last Posted Date: 2023-07-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT03245645

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Transcutaneous Electrical Acupoint Stimulation (TEAS) for Chronic Constipation

Not Applicable

Recruiting

Conditions: Constipation - Functional

Interventions: Device: Verum TEAS
Device: Sham TEAS

First Posted Date: 2017-08-09

Last Posted Date: 2023-10-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 100

Registration Number: NCT03243955

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD

Phase 2

Active, not recruiting

Conditions: ASD

Interventions: Drug: L-DOPA versus Placebo
Behavioral: Social Skills Training

First Posted Date: 2017-08-09

Last Posted Date: 2023-06-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 56

Registration Number: NCT03243552

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Minocycline for Alcohol Use Disorder

Phase 1

Withdrawn

Conditions: Alcohol Drinking
Alcohol Use Disorder
Inflammation
Neurocognitive Dysfunction
Craving

Interventions: Drug: Sugar pill
Drug: Minocycline

First Posted Date: 2017-08-09

Last Posted Date: 2019-01-24

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT03244592

Walnut Consumption and Diabetes Risk

Completed

Conditions: Diabetes Mellitus

Interventions: Diagnostic Test: Diabetes Outcome

First Posted Date: 2017-07-21

Last Posted Date: 2017-07-21

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 34121

Registration Number: NCT03224533

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy